4//SEC Filing
FIVE PRIME THERAPEUTICS INC 4
Accession 0001209191-16-122503
CIK 0001175505operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 3:03 PM ET
Size
5.3 KB
Accession
0001209191-16-122503
Insider Transaction Report
Form 4
Douglas R Lee
Director
Transactions
- Award
Stock Option (right to buy)
2016-05-19+10,000→ 0 totalExercise: $42.25Exp: 2026-05-19→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option will vest in its entirety on the earlier to occur of (i) May 19, 2017 or (ii) the day before the 2017 annual meeting of stockholders of Five Prime Therapeutics, Inc.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175505
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 3:03 PM ET
- Size
- 5.3 KB